MDM1EA

N-Methyl-1-(3,4-methylenedioxyphenyl)-1-ethanamine (MDM1EA), also known as α,N-dimethyl-3,4-methylenedioxybenzylamine (α,N-DMMDBA) or as α,N-dimethylpiperonylamine, is an entactogen-like drug of the benzylamine family related to MDMA.^[1][2][3] It is the analogue of MDMA in which the side chain has been shortened by one carbon atom.^[1][2][3]

MDM1EA

Clinical data
Other names	N-Methyl-1-(3,4-methylenedioxyphenyl)-1-ethanamine; MDM1EA; α,N-Dimethyl-3,4-methylenedioxybenzylamine; α,N-DMMDBA; α,N-Dimethylpiperonylamine; α,N-Dimethyl-1,3-benzodioxole-5-methanamine
Identifiers
IUPAC name 1-(1,3-benzodioxol-5-yl)-N-methylethanamine
CAS Number	121734-65-4
PubChem CID	6424509
ChemSpider	4930000
Chemical and physical data
Formula	C10H13NO2
Molar mass	179.219 g·mol−1
3D model (JSmol)	Interactive image
SMILES CC(C1=CC2=C(C=C1)OCO2)NC
InChI InChI=1S/C10H13NO2/c1-7(11-2)8-3-4-9-10(5-8)13-6-12-9/h3-5,7,11H,6H2,1-2H3 Key:USAUUVXZKYYZIL-UHFFFAOYSA-N

The drug has been found to be a weak serotonin reuptake inhibitor and partially substituted for MDMA in rodent drug discrimination tests at the highest assessed doses.^[1][2][4][3] The effects of α,N-DMMDBA in humans are unknown.^[1]

It is not a controlled substance in the United States as of 2011.^[1]

Homo-MDMA (HMDMA), an analogue of MDMA in which the side chain was extended by one carbon atom, has also been synthesized and studied.^[2][3] It partially substituted for MDMA similarly to MDM1EA.^[2][3]

See also

• ALPHA
• M-ALPHA
• Benzylpiperazine (BZP)
• Methylenedioxybenzylpiperazine (MDBZP)
• Homo-MDA
• Homo-MDMA